LATEST UK MEDTECH NEWS
1. Med-Tech Innovation Expo takes place on 8th-9th June in Birmingham
Do not miss the most innovative and exciting event in medical technology. At the Med-Tech Innovation Expo, you will enjoy technical exhibitions and exciting content focused on MedTech, medical plastics, digital devices, pharmaceutical manufacturing technologies, start-ups. You will have a great opportunity to discuss the hottest topics in medical technology with world leaders in this field. The event will take place June 8-9 at the Birmingham National Exhibition Centre.
Register via this link on the event’s website where you can also find more information about speakers, exhibitions and see the detailed program of the Med-Tech Innovation Expo.
2. Medical device company Medovate named "Medtech Company of the Year"
Medovate is a UK-based medical device company dedicated to manufacturing innovative new medical devices and bringing them to market to help improve patient care. The company has been awarded “Medtech Company of the Year” at the Cambridge Independent Science and Technology Awards 2022.
The company went through a record number of entries and won, reflecting the talent in the Cambridgeshire region. Expert panel was impressed that only in four years, Medovate has developed several innovative medical devices. For example, Medovate introduced Endovac, an endoscopic surgical device that helps improve survival of patients with life threatening infection. Medovate’s CEO Stuart Thomson was also shortlisted for “CEO of the Year” at this year’s awards, which took place at Hinxton Hall Conference Centre.
3. Philips launches new solution to treat structural heart disease
Technology giant Philips has transformed into a focused leader in health technology over the past decade. The company has been developing innovative products to improve people’s health and well-being through meaningful innovation.
Recently, Philips has announced the international launch of EchoNavigator 4.0, the new release of its image-guided therapy solution for the treatment of structural heart disease. EchoNavigator 4.0 helps to treat complex structural heart disease therapy, such as heart valve repair or replacement. Philips EchoNavigator can improve teamwork between echocardiographers and interventionists during image-guided therapy by automatically fusing together echocardiography ultrasound and X-ray images, while enhancing understanding of the relationship between X-ray and ultrasound in a way that helps interventional teams to complete procedures with greater safety, confidence, and clarity.
4. Medtech start-up company VisusNano has been awarded £1.39m for implant used in cataract surgery
United Kingdom's innovation agency Innovate UK provided £1.39m to further develop MEDILens, a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. The funding will allow VisusNano to test the safety and efficacy of MEDILens in fighting the cataract which is the most common cause of treatable blindness worldwide.
5. University of Birmingham develops Long COVID symptoms assessment tool
For some people, coronavirus can cause symptoms that last weeks or months after the infection has gone. This is sometimes called post-COVID-19 syndrome or "long COVID". The scientists at the University of Birmingham have developed a tool that can assess and catch the symptoms of Long COVID. The team from the University of Birmingham’s Centre plans to carry out more development and testing to explore how the tool can be used in routine clinical practice, including translating it for use in other countries and minority ethnic communities.
6. Medtech start-up 52 North Health has raised £1 million
52 North Health, a UK and US-based medtech start-up, has raised £1 million in its first round of funding from leading UK and European specialist investors. 52 North is developing the NeutroCheck: a fully integrated clinical, AI and medical device-based system for people living with cancer. The NeutroCheck is a point-of-care medical device which can be used by patients outside of hospital to monitor their risk of neutropenic sepsis, a potentially life-threatening complication of chemotherapy.
OF OUR POSTS